US equities |
NVDA $240.04 ▲+0.48% SPCX $173.03 ▲+1.13% MU $1,066.24 ▲+0.21% MRVL $289.05 ▲+6.56% AMD $654.64 ▲+3.62% AVGO $379.08 ▲+4.57% INTC $114.76 ▼-1.23% TSLA $380.25 ▲+0.40%
FinancialContent

VivoSim Labs, Inc. - Common Stock (NQ:VIVS)

0.2039 -0.0025 (-1.21%)
Delayed Quote Updated: 1:54 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about VivoSim Labs, Inc. - Common Stock

< Previous 1 2 Next >
Which stocks are moving before the opening bell on Wednesday? ↗
Via Chartmill
News headline image
VivoSim Announces Pricing of up to a $4 Million Public Offering
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload toxicity and show differential linker chemistry toxicity 
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
Veteran business development leader with deep expertise in human-relevant NAM and spheroid-based in vitro services to spearhead commercial growth along the US East Coast, deepening VivoSim’s reach with... 
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
Company produces thorough reference testing on Antibody Drug Conjugates, showing high correlation with clinical liver and intestinal toxicity and side effects 
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
Why Is VIVS Stock Up 79% Today? ↗
VivoSims said on Friday that it has signed JCBio as an authorized distributor in Korea and Tekon Biotech as an authorized distributor in China for its NAMKind human-based toxicology services. 
Via Stocktwits
Topics Animal Testing
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
JCBio appointed for Korea; Tekon Biotech appointed for China provide access to liver and small-intestine NAM screening with “molecules in, data out” speed and human relevance 
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
Distinguished drug-development and biomarker leader to advance NAMkind™ scientific strategy, translational insights, and next-generation toxicology platforms 
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
These stocks are moving in today's session ↗
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Roadzen Inc. (NASDAQ: RDZN) Accelerates U.S. Expansion with Strategic Acquisition – Surges on Record Volume – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Tuesday's session: top gainers and losers ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
Unusual volume stocks in Tuesday's session ↗
Unusual volume stocks are being observed in Tuesday's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing market 
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference
From VivoSim Labs, Inc.
Via GlobeNewswire
< Previous 1 2 Next >